Comparison of anti-inflammatory effects and high-density lipoprotein cholesterol levels between therapy with quadruple-dose rosuvastatin and rosuvastatin combined with ezetimibe

BACKGROUND: Statins are frequently administered to reduce low-density lipoprotein cholesterol (LDL-C) and vascular inflammation, because LDL-C and high sensitive C-reactive protein (hs-CRP) are associated with high risk for cardiovascular events. When statins do not reduce LDL-C to desired levels in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yamazaki, Daisuke, Ishida, Masaru, Watanabe, Hiroyuki, Nobori, Kiyoshi, Oguma, Yasunori, Terata, Yutaka, Koyama, Takashi, Iino, Kenji, Kosaka, Toshimitsu, Ito, Hiroshi
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3598241/
https://ncbi.nlm.nih.gov/pubmed/23374898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-511X-12-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados